Contenu disponible en anglais seulement.

Négociation suspendue de la TSX - Valeo Pharma Inc. (VPH, VPH.DB)

2 octobre 2024
Issuer: Valeo Pharma Inc.
Securities:

Class A Shares
12% Convertible Unsecured Subordinated Debentures
 
(Collectively, the "Securities")

Symbol(s):

VPH
VPH.DB

Delisting Review Type: Expedited
Reason: TSX is reviewing the Securities with respect to meeting the requirements for continued listing pursuant to the Expedited Review Process.
Trading: The Securities are suspended from trading immediately.
TSX contact: Anne Child,
Managing Director,
TSX Listings